Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

Status unconfirmed · Not applicable

Conditions studied: Nicotine Dependence

In brief

The primary aim of this study is to conduct a 60-patient feasibility, acceptability, and preliminary efficacy study of mSMART (Mobile App based Personalized Solutions and Tools for Medication Adherence of Rx Pill), a smartphone application ("app") for improving medication adherence among substance users. The investigators will compare 2 groups of cigarette smokers undergoing a quit attempt with varenicline (Chantix): a) an experimental group using the mSMART app on their smartphone and a MEMS Cap (Medication Event Monitoring System, a smart pillbox that will a record a date and time-stamped medication event whenever pill box is opened and closed, and thus allow for primary measurement of medication adherence) and b) a control group using the MEMS Cap and mobile web-based surveys on their smartphone.

Key facts

Study ID

NCT02635919

Run by

Duke University

People needed

60

Starts

2016-04-01

Expected to finish

2018-11-01

Last updated by the study team

2018-04-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Recently prescribed varenicline (Chantix) with the intention to quit smoking in the next 3 months
• Has an Android smartphone (using v5.x.x or lollipop) or Apple smartphone (iPhone) Operating System (iOS) (using v6.0)

You may not qualify if…

• Unwillingness to be randomized to either treatment condition
• Use of only non-cigarette forms of tobacco (i.e., participant is not a cigarette smoker but instead uses other tobacco products)

Where it is running

• Duke Health Behavior Neuroscience Research Lab — Durham, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.